specialty drug costs

Ten ways hospitals can manage rising drug costs
Ten ways hospitals can manage rising drug costsFluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causesAlbert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow address the underlying disease process.
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy SummitThe conference raised important points about value-based contracts and the specialty pharmacy space.
What’s in the Specialty Pharmacy Pipeline?
What’s in the Specialty Pharmacy Pipeline?Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.
Creating a ‘robust’ specialty pharmacy networkThe correct approach to take when creating a specialty pharmacy network is a key issue for healthcare executives.
Specialty pharmaceuticals: Solving top challenges
Specialty pharmaceuticals: Solving top challengesManaged Healthcare Executive recently invited a panel of experts representing different sectors of the healthcare industry to explore specialty pharmaceutical challenges and identify potential solutions.
Predictions for the future of high-cost specialty drugsIMS Health expert predicts future drug spending trends and ways to curb rising costs at the AMCP 2016 conference.
Are your prior auth provisions stifling medication adherence?Prior authorizations are here to stay. Are yours working against you? Find out.
Report: Specialty drugs unaffordable for consumersA new AARP report shows that the rapid rise in cost of specialty drugs exceeds median family income.
Cost vs. value: Healthcare shifts its focusValue-based care is transforming the world of healthcare. Simple cost management must give way to utilization management, and alignment of stakeholder services is inevitable.